Engineering of Long-Circulating Peptidoglycan Hydrolases Enables Efficient Treatment of Systemic <named-content content-type="genus-species">Staphylococcus aureus</named-content> Infection

Engineering of Long-Circulating Peptidoglycan Hydrolases Enables Efficient Treatment of Systemic <named-content content-type="genus-species">Staphylococcus aureus</named-content> Infection

ABSTRACT Staphylococcus aureus is a human pathogen causing life-threatening diseases. The increasing prevalence of multidrug-resistant S. aureus infections is a global health concern, requiring development of novel therapeutic options. Peptidoglycan-degrading enzymes (peptidoglycan hydrolases, PGHs)...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Anna M. Sobieraj, Markus Huemer, Léa V. Zinsli, Susanne Meile, Anja P. Keller, Christian Röhrig, Fritz Eichenseher, Yang Shen, Annelies S. Zinkernagel, Martin J. Loessner, Mathias Schmelcher
Format: article
Langue:EN
Publié: American Society for Microbiology 2020
Sujets:
endolysin
protein therapeutic
antibiotic resistance
MRSA
circulation half-life
Microbiology
QR1-502
Accès en ligne:https://doaj.org/article/db6d42fc26334af090638c286d488157
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/db6d42fc26334af090638c286d488157

Documents similaires